Virtus ETF Advisers LLC Seagen Inc. Transaction History

Virtus ETF Advisers LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $5,231 - $8,326	41 Added 1.79%	2,332 $472,000
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $77,581 - $91,991	661 Added 40.55%	2,291 $294,000
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $3,517 - $4,682	26 Added 1.62%	1,630 $223,000
Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $105,654 - $174,129	-971 Reduced 37.71%	1,604 $284,000
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $49,899 - $66,801	-350 Reduced 11.97%	2,575 $398,000
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $38,461 - $45,851	-270 Reduced 8.45%	2,925 $497,000
Q2 2021 Aug 10, 2021	SELL	$135.08 - $161.1 $4,592 - $5,477	-34 Reduced 1.05%	3,195 $504,000
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $444,019 - $616,093	3,229 New	3,229 $448,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.